SCHEMBL16812613

SCHEMBL16812613

O=C(NC1CCN(c2ccc(CN3CCC(NC(=O)c4cccc(-c5ccc(OC(F)(F)F)cc5)c4Cl)CC3)cn2)CC1)c1cccc(-c2cccnc2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMO Q99835 1/20 0.70
▸ DRD4 P21917 3/20 0.49
▸ HTR2A P28223 2/20 0.49
▸ DRD2 P14416 1/20 0.49
▸ SLC6A5 Q9Y345 1/20 0.47
▸ PDCD1 Q15116 2/20 0.46
▸ CD274 Q9NZQ7 2/20 0.46
▸ SSTR5 P35346 1/20 0.45
▸ CHRM4 P08173 2/20 0.43
▸ SCN5A Q14524 1/20 0.43
▸ SCN9A Q15858 1/20 0.43
▸ WNT1 P04628 1/20 0.42
▸ DYRK1A Q13627 1/20 0.42
▸ PRKAB2 O43741 2/20 0.42
▸ PRKAG1 P54619 2/20 0.42
▸ PRKAA2 P54646 2/20 0.42
▸ PRKAA1 Q13131 2/20 0.42
▸ PRKAG3 Q9UGI9 2/20 0.42
▸ PRKAG2 Q9UGJ0 2/20 0.42
▸ PRKAB1 Q9Y478 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16812761 0.93 SMO (0.69) SMODRD4HTR2ADRD2SLC6A5
SCHEMBL16812611 0.93 SMO (0.71) SMODRD4HTR2ADRD2SLC6A5
SCHEMBL16812612 0.93 SMO (0.70) SMODRD4HTR2ADRD2SLC6A5
SCHEMBL16811868 0.92 SMO (0.84) SMODRD4DRD2SLC6A5PDCD1
SCHEMBL16811866 0.92 SMO (0.84) SMODRD4DRD2SLC6A5PDCD1
SCHEMBL16812608 0.91 SMO (0.72) SMODRD4HTR2ADRD2SLC6A5
SCHEMBL18286588 0.90 SMO (0.53) SMODRD4HTR2ADRD2SLC6A5
SCHEMBL16811983 0.90 SMO (0.79) SMODRD4HTR2ADRD2SLC6A5
SCHEMBL16811993 0.90 SMO (0.76) SMODRD4HTR2ADRD2PDCD1
SCHEMBL16812607 0.89 SMO (0.73) SMODRD4HTR2ADRD2SLC6A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9512106-B2 Smoothened modulators and methods of use thereof DUKE UNIVERSITY (US) 2016-12-06 — — US disclosed
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF UNIV DUKE (US) 2015-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF SMO, SHH, GLI1 SMO 1/4885DRD4 4828/4885HTR2A 3023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback